Skip to main content

Table 2 Hepatitis B serum markers

From: Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature

  HBsAg(COI) anti- HBs(IU/L) HBeAg(COI) HBeAb(COI) HBcAb(COI)
2012–11 28.1 < 2 0.1 0.011 0.009
2013–11 11.11 < 2 0.076 0.008 0.005
2016–06 5.11 < 2 0.03 0.043 0.003
2017–12 2.36 < 2 0.111 0.084 0.010